William (Bill) Nichols, Jr.
Equibles does not estimate personal net worth.
About William (Bill) Nichols, Jr.
Protagenic Therapeutics, Inc.\new reported in an 8-K filed March 3, 2026 that William (Bill) Nichols, Jr. was appointed President, effective February 3, 2026. Protagenic Therapeutics, Inc.\new is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Protagenic Therapeutics, Inc.\new includes Barrett Evans (CEO and Board Member), Garo H. Armen (Chairman and Board Member), Alexander K. Arrow (CFO) and 5 others.
“On February 3, 2026, the Board of Directors (the "Board") of Protagenic Therapeutics, Inc. (the "Company") appointed William (Bill) Nichols, Jr., age 51, as President of the Company.”
Affiliation history
-
Current
2026-02-03–present
Company network
Leadership on record at Protagenic Therapeutics, Inc.\new
- Barrett Evans CEO, Board Member
- Garo H. Armen Chairman, Board Member
- Alexander K. Arrow CFO
- Andrew Slee COO
- Colin Stott COO, Board Member
- Brian J. Corvese Board Member
- Jennifer Buell, Ph.D. Board Member
- Jennifer Chao Board Member